Young Adults With Anterior Ischemic Optic Neuropathy: A Multicenter Optic Disc Drusen Study.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
09 2020
Historique:
received: 04 03 2020
accepted: 31 03 2020
pubmed: 17 4 2020
medline: 7 10 2020
entrez: 17 4 2020
Statut: ppublish

Résumé

Optic disc drusen (ODD), present in 2% of the general population, have occasionally been reported in patients with nonarteritic anterior ischemic optic neuropathy (NA-AION). The purpose of this study was to examine the prevalence of ODD in young patients with NA-AION. Retrospective, cross-sectional multicenter study. All patients with NA-AION 50 years old or younger, seen in neuro-ophthalmology clinics of the international ODDS (Optic Disc Drusen Studies) Consortium between April 1, 2017, and March 31, 2019, were identified. Patients were included if ODD were diagnosed by any method, or if ODD were excluded by enhanced-depth imaging optical coherence tomography (EDI-OCT) using ODDS Consortium guidelines. NA-AION eyes with ODD were termed "ODD-AION"; those without were termed "NODD-AION". A total of 65 patients (127 eyes) with NA-AION were included (mean 41 years old). Of the 74 eyes with NA-AION, 51% had ODD-AION, whereas 43% of fellow eyes without NA-AION had ODD (P = .36). No significant differences were found between ODD-AION and NODD-AION eyes in terms of Snellen best-corrected VA or perimetric mean deviation. According to EDI-OCT results, 28% of eyes with NODD-AION had peripapillary hyperreflective ovoid mass-like structures (PHOMS); 7% had hyperreflective lines, whereas 54% with ODD-AION had PHOMS; and 66% had hyperreflective lines (P = .006 and P < .001, respectively). Most of these young NA-AION patients had ODD. This indicates that ODD may be an independent risk factor for the development of NA-AION, at least in younger patients. This study suggests ODD-AION be recognized as a novel diagnosis.

Identifiants

pubmed: 32298654
pii: S0002-9394(20)30164-1
doi: 10.1016/j.ajo.2020.03.052
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

174-181

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Steffen Hamann (S)

Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: steffen.hamann@regionh.dk.

Lasse Malmqvist (L)

Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Marianne Wegener (M)

Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Masoud Aghsaei Fard (MA)

Farabi Eye Hospital, Tehran University of Medical Science, Tehran, Iran.

Valérie Biousse (V)

Farabi Eye Hospital, Tehran University of Medical Science, Tehran, Iran.

Lulu Bursztyn (L)

Department of Ophthalmology, Western University, London, Ontario, Canada.

Gülsenay Citirak (G)

Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Fiona Costello (F)

Departments of Clinical Neurosciences and Surgery, University of Calgary, Canada.

Alison V Crum (AV)

Department of Ophthalmology and Visual Sciences, Department of Neurology, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

Kathleen Digre (K)

Department of Ophthalmology and Visual Sciences, Department of Neurology, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

J Alexander Fraser (JA)

Department of Ophthalmology, Western University, London, Ontario, Canada; Department of Clinical Neurological Sciences, Western University, London, Ontario, Canada.

Ruth Huna-Baron (R)

Goldschleger Eye Institute, Sheba Medical Center, el HaShomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel.

Bradley Katz (B)

Department of Ophthalmology and Visual Sciences, Department of Neurology, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

Mitchell Lawlor (M)

Save Sight Institute Faculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.

Nancy J Newman (NJ)

Departments of Ophthalmology and Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.

Jason H Peragallo (JH)

Departments of Ophthalmology and Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.

Axel Petzold (A)

Moorfields Eye Hospital, National Hospital for Neurology and Neurosurgery, Queen Square Institute of Neurology, University College of London, London, United Kingdom; Neuro-Ophthalmology Expertise Centre, VU University Medical Center, Amsterdam, the Netherlands.

Patrick A Sibony (PA)

Department of Ophthalmology, State University of New York at Stony Brook, Stony Brook, New York, USA.

Prem S Subramanian (PS)

Departments of Ophthalmology, Neurology, and Neurosurgery, Sue Anschutz-Rodgers UC Health Eye Center, University of Colorado School of Medicine, Denver, Colorado, USA.

Judith E A Warner (JEA)

Department of Ophthalmology and Visual Sciences, Department of Neurology, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

Sui H Wong (SH)

Department of Neuro-Ophthalmology, Moorfields Eye Hospital, London, United Kingdom.

Clare L Fraser (CL)

Save Sight Institute Faculty of Health and Medicine, The University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH